Pfizer has admitted that the immunity induced by its coronavirus vaccine is waning and it is making efforts to develop a booster dose that will protect people from the variants of the vir ...
Islamabad/UNI: Pakistan has entered into an agreement with Pfizer Pakistan under which the company would supply 13 million doses of the American vaccine to the country.
Washington/Sputnik: No COVID-19 variant has escaped the protection of Pfizer's vaccine, but the company continues to monitor and test it against emerging strains around the world, CEO ...
Moscow/Sputnik: The Japanese government approved Pfizer's COVID-19 vaccine for ages 12 to 15 on Monday, the media reported.
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing fede ...
Washington/Sputnik: Pfizer’s experimental oral drug to treat COVID-19 at the first sign of illness could be available before the end of the year, Chief Executive Albert Bourla told ...
Washignton: A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care person ...
Moscow/Sputnik: The efficacy of the Pfizer coronavirus vaccine (official name BNT162b2) might sustain against the newly-detected mutant strains from the United Kingdom and South Africa, a ...
Athens/Sputnik: One case of an allergic reaction to the Pfizer/BioNTech coronavirus vaccine has been reported in Greece, Primary Health Care Secretary General Marios Themistokleous said a ...
- Pfizer to manufacture its Covid-19 vaccine in South Africa
- Pfizer bats for booster shot as immunity from its vaccine shows decline
- Covid-19: Pfizer to supply 13 million doses of vaccine to Pakistan
- Pfizer vaccine is effective against all existing COVID-19 variants, says CEO
- Pfizer's COVID vaccine approved for minors aged 12-15 in Japan